Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

Giovanni F.M. Strippoli; Allison Tong; David W. Johnson; Francesco Paolo Schena; Jonathan C. Craig

doi:10.1002/14651858.CD004679.pub2

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

Giovanni F.M. Strippoli, Allison Tong, David W. Johnson, Francesco Paolo Schena, Jonathan C. Craig

Research output: Contribution to journal › Article

59 Citations (Scopus)

Abstract

People with advanced kidney disease may be treated with peritoneal dialysis where a catheter is permanently inserted into the peritoneum (lining around abdominal contents) through the abdominal wall and sterile fluid is drained in and out a few times each day. The most common serious complication is infection of the peritoneum ‐ peritonitis. This may be caused by bacteria accidentally being transferred from the catheter. This review found that nasal mupirocin reduces exit‐site/tunnel infection but not peritonitis while preoperative intravenous antibiotic prophylaxis reduces early peritonitis but not exit‐site/tunnel infection. More large scale trials are needed.

Original language	English
Article number	CD004679
Journal	Cochrane Database of Systematic Reviews
Volume	2004
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD004679.pub2
Publication status	Published - 18 Oct 2004
Externally published	Yes

Keywords

dialysis therapy
peritonitis
Antimicrobial agents

Access to Document

10.1002/14651858.CD004679.pub2Licence: In Copyright

Fingerprint Dive into the research topics of 'Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients'. Together they form a unique fingerprint.

Cite this

@article{b1fddf31e3dd446cabf19c28c5e4425d,

title = "Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients",

abstract = "People with advanced kidney disease may be treated with peritoneal dialysis where a catheter is permanently inserted into the peritoneum (lining around abdominal contents) through the abdominal wall and sterile fluid is drained in and out a few times each day. The most common serious complication is infection of the peritoneum ‐ peritonitis. This may be caused by bacteria accidentally being transferred from the catheter. This review found that nasal mupirocin reduces exit‐site/tunnel infection but not peritonitis while preoperative intravenous antibiotic prophylaxis reduces early peritonitis but not exit‐site/tunnel infection. More large scale trials are needed. ",

keywords = "dialysis therapy, peritonitis, Antimicrobial agents",

author = "Strippoli, {Giovanni F.M.} and Allison Tong and Johnson, {David W.} and Schena, {Francesco Paolo} and Craig, {Jonathan C.}",

year = "2004",

month = oct,

day = "18",

doi = "10.1002/14651858.CD004679.pub2",

language = "English",

volume = "2004",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "UPDATE SOFTWARE LTD",

number = "4",

}

TY - JOUR

T1 - Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

AU - Strippoli, Giovanni F.M.

AU - Tong, Allison

AU - Johnson, David W.

AU - Schena, Francesco Paolo

AU - Craig, Jonathan C.

PY - 2004/10/18

Y1 - 2004/10/18

N2 - People with advanced kidney disease may be treated with peritoneal dialysis where a catheter is permanently inserted into the peritoneum (lining around abdominal contents) through the abdominal wall and sterile fluid is drained in and out a few times each day. The most common serious complication is infection of the peritoneum ‐ peritonitis. This may be caused by bacteria accidentally being transferred from the catheter. This review found that nasal mupirocin reduces exit‐site/tunnel infection but not peritonitis while preoperative intravenous antibiotic prophylaxis reduces early peritonitis but not exit‐site/tunnel infection. More large scale trials are needed.

AB - People with advanced kidney disease may be treated with peritoneal dialysis where a catheter is permanently inserted into the peritoneum (lining around abdominal contents) through the abdominal wall and sterile fluid is drained in and out a few times each day. The most common serious complication is infection of the peritoneum ‐ peritonitis. This may be caused by bacteria accidentally being transferred from the catheter. This review found that nasal mupirocin reduces exit‐site/tunnel infection but not peritonitis while preoperative intravenous antibiotic prophylaxis reduces early peritonitis but not exit‐site/tunnel infection. More large scale trials are needed.

KW - dialysis therapy

KW - peritonitis

KW - Antimicrobial agents

U2 - 10.1002/14651858.CD004679.pub2

DO - 10.1002/14651858.CD004679.pub2

M3 - Article

VL - 2004

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 4

M1 - CD004679

ER -